NO944906L - Ny anvendelse av benzo[gÅkinolinderivater - Google Patents
Ny anvendelse av benzo[gÅkinolinderivaterInfo
- Publication number
- NO944906L NO944906L NO944906A NO944906A NO944906L NO 944906 L NO944906 L NO 944906L NO 944906 A NO944906 A NO 944906A NO 944906 A NO944906 A NO 944906A NO 944906 L NO944906 L NO 944906L
- Authority
- NO
- Norway
- Prior art keywords
- gåquoline
- benzo
- derivatives
- new use
- new
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939326010A GB9326010D0 (en) | 1993-12-21 | 1993-12-21 | Improvements in or relating to organic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO944906D0 NO944906D0 (no) | 1994-12-19 |
| NO944906L true NO944906L (no) | 1995-06-22 |
Family
ID=10746904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO944906A NO944906L (no) | 1993-12-21 | 1994-12-19 | Ny anvendelse av benzo[gÅkinolinderivater |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0659430A1 (no) |
| JP (1) | JPH07215872A (no) |
| KR (1) | KR950016753A (no) |
| CN (1) | CN1109332A (no) |
| AU (1) | AU689510B2 (no) |
| CA (1) | CA2138421A1 (no) |
| CZ (1) | CZ324094A3 (no) |
| GB (1) | GB9326010D0 (no) |
| HU (1) | HUT71497A (no) |
| IL (1) | IL112021A0 (no) |
| NO (1) | NO944906L (no) |
| PL (1) | PL306367A1 (no) |
| RU (1) | RU94045256A (no) |
| SK (1) | SK155994A3 (no) |
| ZA (1) | ZA9410210B (no) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2251857A1 (en) * | 1996-04-17 | 1997-10-23 | Tohru Tatsuno | Remedy for retinal neuropathy |
| TW378209B (en) * | 1996-07-08 | 2000-01-01 | Novartis Ag | Benzo[g]quinoline derivatives, their preparation and the pharmaceutical composition containing them |
| US5922746A (en) * | 1997-03-27 | 1999-07-13 | Allergan | Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucoma |
| SE0001438D0 (sv) | 2000-04-18 | 2000-04-18 | Axon Chemicals Bv | New chemical compounds and their use in therapy |
| EP1336102A2 (en) | 2000-11-22 | 2003-08-20 | Allergan, Inc. | A high-throughput screen for identifying channel blockers that selectively distinguish transient from persistent sodium channels |
| PE20030240A1 (es) | 2001-07-09 | 2003-04-16 | Novartis Ag | DERIVADOS DE BENZO [g] QUINOLINA |
| US6479458B1 (en) | 2001-11-08 | 2002-11-12 | Allergan, Inc. | Targeting the reverse mode of the Na+/Ca2+ exchanger for the treatment of optic neuropathy associated with glaucoma and ischemic optic neuropathy |
| US7361478B2 (en) | 2001-11-20 | 2008-04-22 | Allergan, Inc. | High-throughput screen for identifying selective persistent sodium channels channel blockers |
| EG24415A (en) * | 2002-03-07 | 2009-05-25 | Novartis Ag | Quinoline derivatives |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4405626A (en) * | 1980-10-03 | 1983-09-20 | Pfizer Inc. | 9-Hydroxyoctahydrobenzo(c)quinolines analgesic compositions containing them and processes for producing analgesic with them |
| DE19575006I2 (de) * | 1981-10-16 | 2003-01-09 | Novartis Ag | 1, 2, 3, 4a, 5, 10, 10a-Octahydrobenzo(g)chinolin-Derivate mit pharmazeutischer Wirkung |
| FI873429A7 (fi) * | 1986-08-18 | 1988-02-19 | Houston Biotechnology Incorporated | Silmälääketieteelliset koostumukset hermodegeneraatioiden hoitoon. |
| US5262422A (en) * | 1991-05-02 | 1993-11-16 | Sandoz Ltd. | Octahydrobenzo[g]quinoline |
| DE4114325A1 (de) * | 1991-05-02 | 1992-11-05 | Sandoz Ag | Octahydrobenzo(g)chinolin, seine herstellung und verwendung |
-
1993
- 1993-12-21 GB GB939326010A patent/GB9326010D0/en active Pending
-
1994
- 1994-12-19 KR KR1019940034994A patent/KR950016753A/ko not_active Withdrawn
- 1994-12-19 SK SK1559-94A patent/SK155994A3/sk unknown
- 1994-12-19 EP EP94810733A patent/EP0659430A1/en not_active Withdrawn
- 1994-12-19 PL PL94306367A patent/PL306367A1/xx unknown
- 1994-12-19 CA CA002138421A patent/CA2138421A1/en not_active Abandoned
- 1994-12-19 HU HU9403653A patent/HUT71497A/hu unknown
- 1994-12-19 CZ CZ943240A patent/CZ324094A3/cs unknown
- 1994-12-19 NO NO944906A patent/NO944906L/no unknown
- 1994-12-19 IL IL11202194A patent/IL112021A0/xx unknown
- 1994-12-19 AU AU81522/94A patent/AU689510B2/en not_active Expired - Fee Related
- 1994-12-20 RU RU94045256/14A patent/RU94045256A/ru unknown
- 1994-12-20 JP JP6316370A patent/JPH07215872A/ja active Pending
- 1994-12-20 CN CN94120200A patent/CN1109332A/zh active Pending
- 1994-12-21 ZA ZA9410210A patent/ZA9410210B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK155994A3 (en) | 1995-07-11 |
| CA2138421A1 (en) | 1995-06-22 |
| AU689510B2 (en) | 1998-04-02 |
| ZA9410210B (en) | 1996-06-21 |
| EP0659430A1 (en) | 1995-06-28 |
| NO944906D0 (no) | 1994-12-19 |
| PL306367A1 (en) | 1995-06-26 |
| GB9326010D0 (en) | 1994-02-23 |
| IL112021A0 (en) | 1995-03-15 |
| HUT71497A (en) | 1995-11-28 |
| JPH07215872A (ja) | 1995-08-15 |
| KR950016753A (ko) | 1995-07-20 |
| HU9403653D0 (en) | 1995-02-28 |
| AU8152294A (en) | 1995-06-29 |
| CZ324094A3 (en) | 1995-09-13 |
| CN1109332A (zh) | 1995-10-04 |
| RU94045256A (ru) | 1996-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO953244D0 (no) | Derivater av cyklodepeptid PF 1022 | |
| BR9507179A (pt) | Derivados de 3-aril-4-hidróxi-delta3-dihidrotiofena | |
| NO921217L (no) | Silyletere av rapamycin | |
| NO921976L (no) | Amidestere av rapamycin | |
| FI935223A0 (fi) | RAKE-mottagare med selektiv kombinering av straolar | |
| NO20001628D0 (no) | Polymerderivater av kamptoteciner | |
| DE69612852D1 (de) | BENZO[g]CHINOLINDERIVATE | |
| FI931408A0 (fi) | Anordning foer fraesning av amorfiska staolremsor | |
| FI933814L (fi) | Framstaellning av faktor-ix | |
| NO944906L (no) | Ny anvendelse av benzo[gÅkinolinderivater | |
| NO960699D0 (no) | Antimigren 1,2,5-tiadiazolderivater av indolylalkylpyridinyl- og -pyrimidinylpiperaziner | |
| FI963531A0 (fi) | Kinoliini-3-karboksamidiyhdisteiden uusi käyttö | |
| FI973500A0 (fi) | 3-pyrrolidylideeni-2-oni-kefalosporiinien johdannaiset | |
| FI963532A0 (fi) | Kinoliini-3-karboksamidiyhdisteiden uusi käyttö | |
| NO940190D0 (no) | Anvendelse av x-ketoglutarat | |
| FI944714A0 (fi) | Beta-karboliinien uusi käyttö | |
| NO931399D0 (no) | Anvendelse av naturstein | |
| NO974143D0 (no) | Farmakologisk anvendelse av visse cystinderivater | |
| NO920272D0 (no) | Hydrofile-hydrofobe derivater av polygalaktomannaner inneholdende tertiaer aminfunksjonalitet | |
| NO993069D0 (no) | Ny anvendelse av dipeptider | |
| BR9508669A (pt) | Novos derivados de taizoloÚ3,2-a¾quinolina e naftirina | |
| NO306861B1 (no) | Asymmetrisk hydrogenering av furoimidazol-derivater | |
| NO954984D0 (no) | Ny anvendelse av Ambasilide | |
| BR9704770A (pt) | Derivados de 1-carba-(detia)-cefalosporina | |
| NO943793D0 (no) | Ny anvendelse av |